Anatomic Pathology Market worth $14.5 billion by 2031
The report "Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) – Global Forecast to 2031", is projected to grow from USD 8.9 billion in 2026 and to reach USD 14.5 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Browse 500 market data Tables and 51 Figures spread through 400 Pages and in-depth TOC on "Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) – Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
The anatomic pathology market is experiencing significant growth, largely fueled by the increasing global burden of cancer and other chronic diseases. Additionally, the growing adoption of precision medicine, biomarker-driven disease characterization, and advanced pathology workflows is further supporting market expansion. Increasing investments in laboratory capacity, growing numbers of accredited diagnostic facilities, and rising demand for specialized pathology services are creating sustained opportunities for market participants. In addition, efforts to improve access to high-quality diagnostic services are accelerating the deployment of advanced pathology technologies worldwide.
The consumables segment accounted for the largest share of the anatomic pathology market in 2025.
Based on product type, the anatomic pathology market is segmented into consumables, instruments, software, and storage systems. The consumables segment accounted for the largest share of the market in 2025. Consumables in this market include antibodies, probes, stains, reagents, assay kits, fixatives, solvents, and other pathology consumables used across histopathology and cytopathology workflows. Their dominant share reflects the recurring nature of pathology testing, as each tissue or cellular specimen requires multiple consumables throughout tissue preparation, staining, biomarker assessment, and diagnostic interpretation. In addition, the growing volume of pathology examinations, increasing utilization of biomarker testing, and expanding adoption of advanced staining and tissue analysis techniques continue to drive sustained demand for consumables, supporting the segment’s leading position throughout the forecast period.
The hospitals segment accounted for the largest share of the anatomic pathology market in 2025.
The anatomic pathology market, by end user, is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations (CROs), and other end users. The hospitals segment accounted for the largest market share due to the high volume of histopathology, cytopathology, and tissue-based diagnostic procedures performed in hospital settings. Hospitals serve as the primary point of care for cancer diagnosis, surgical pathology evaluation, and disease characterization, driving significant demand for anatomic pathology products and services. Furthermore, increasing investments in pathology infrastructure, growing adoption of advanced staining and tissue analysis technologies, and the integration of digital pathology solutions into hospital laboratories are supporting segment growth. The rising need for timely and accurate diagnostic information to guide clinical decision-making continues to strengthen the position of hospitals as the leading end-user segment in the anatomic pathology market.
The Asia Pacific is expected to register the highest growth rate in the anatomic pathology market during the forecast period.
The anatomic pathology market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is projected to grow at the highest CAGR from 2026 to 2031. China, Japan, and India are the primary growth markets within the region. Japan's well-established healthcare infrastructure, growing cancer burden, and increasing adoption of digital pathology technologies continue to support market expansion. China's healthcare modernization initiatives are driving investments in pathology laboratories, cancer diagnostic services, and advanced tissue analysis technologies across healthcare institutions. Meanwhile, India's rapidly expanding network of tertiary-care hospitals, cancer centers, and diagnostic laboratories is increasing the adoption of automated pathology workflows and advanced diagnostic solutions to support rising disease diagnosis volumes. North America held the largest regional share in 2025, supported by its mature pathology infrastructure, widespread adoption of advanced diagnostic technologies, strong presence of leading market participants, and established utilization of histopathology, cytopathology, and biomarker testing across clinical practice.
The major market players covered in the report include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Koninklijke Philips N.V. (Netherlands), Merck KGaA (Germany), Bio SB (US), and Sakura Finetek Japan Co., Ltd. (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Anatomic Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
